Resmed Income Statement (2009-2025) | RMD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	768.77M	876.10M	904.01M	894.87M	864.50M	914.74M	950.29M	1,033.74M	1,116.90M	1,122.06M	1,102.32M	1,162.80M	1,196.98M	1,223.19M	1,224.51M	1,282.09M	1,291.74M	1,347.99M	1,335.58M	1,422.81M
Cost of Revenue (Quarter)	321.51M	340.28M	386.67M	390.56M	373.30M	352.58M	403.11M	446.72M	490.82M	496.27M	493.35M	515.87M	496.39M	474.70M	499.62M	523.18M	525.33M	550.67M	506.94M	544.08M
Gross Profit (Quarter)	447.26M	490.70M	506.29M	504.32M	491.20M	522.51M	540.81M	579.72M	617.75M	617.39M	600.06M	646.93M	692.78M	715.53M	717.22M	751.27M	766.41M	820.07M	820.82M	878.72M
Operating items
Amortization - Intangibles (Quarter)	7.45M	21.75M	7.71M	7.74M	10.98M	-2.19M	7.95M	9.56M	12.19M	0.69M	12.48M	11.58M	11.20M	11.26M	11.40M	11.05M	10.89M	11.93M	7.82M	11.76M
Research & Development (Quarter)	55.94M	59.88M	59.95M	62.51M	66.80M	64.32M	63.19M	69.87M	76.44M	78.14M	75.71M	73.88M	77.07M	80.86M	79.52M	81.37M	83.94M	86.44M	87.32M	90.97M
Selling, General & Administrative (Quarter)	160.45M	181.48M	176.72M	185.36M	182.40M	193.03M	193.93M	211.67M	228.46M	240.69M	222.87M	222.16M	229.92M	242.19M	238.98M	241.61M	245.30M	265.12M	259.19M	278.40M
Restructuring Costs (Quarter)										10.95M		64.23M		0.03M				2.03M	15.80M	5.90M
Other Operating Expenses (Quarter)	7.45M	7.70M	7.71M	7.74M	7.73M	9.77M	7.95M	17.98M	12.19M	12.34M	12.48M	11.58M	11.20M	11.23M	11.40M	11.05M	10.89M	11.93M	11.97M	11.80M
Operating Expenses (Quarter)	223.83M	249.06M	244.38M	255.61M	256.93M	267.11M	265.07M	299.52M	317.08M	342.12M	311.06M	371.84M	318.20M	334.31M	329.91M	334.03M	340.14M	365.53M	374.28M	387.06M
Operating Income (Quarter)	223.43M	241.64M	261.91M	248.71M	234.26M	255.40M	275.74M	280.19M	300.67M	275.27M	289.00M	275.09M	374.58M	381.22M	387.31M	417.24M	426.27M	454.54M	446.54M	491.66M
EBIT (Quarter)	223.43M	241.64M	261.91M	248.71M	234.26M	255.40M	275.74M	280.19M	300.67M	275.27M	289.00M	275.09M	374.58M	381.22M	387.31M	417.24M	426.27M	454.54M	446.54M	491.66M
Non-operating items
Interest & Investment Income (Quarter)	0.06M	0.06M									-14.96M	-13.80M	-11.03M	-5.92M	-1.66M	-0.78M	0.79M	5.76M	8.79M	7.95M
Other Non Operating Income (Quarter)	4.67M	-0.90M	-1.99M	0.84M	1.88M	2.47M	-1.50M	-1.71M	-2.56M	0.06M	2.65M	-0.69M	-2.50M	-2.96M	-2.44M	2.22M	-4.06M	-0.98M	-3.84M	-5.28M
Non Operating Income (Quarter)	0.70M	-2.43M	-1.99M	-11.43M	-7.95M	2.47M	-13.95M	-1.71M	-2.56M	26.03M	-16.81M	-15.64M	0.84M	-2.96M	-2.44M	2.22M	-8.57M	-0.98M	0.26M	4.49M
Net income details
EBT (Quarter)	218.00M	239.21M	258.79M	237.29M	226.32M	238.09M	261.79M	273.69M	289.38M	276.80M	272.19M	259.45M	375.42M	357.73M	383.50M	418.32M	417.69M	458.05M	446.79M	496.15M
Tax Provisions (Quarter)	296.49M	44.11M	55.17M	35.53M	47.31M	43.03M	51.31M	48.78M	56.88M	47.14M	52.77M	50.65M	74.93M	65.50M	72.14M	73.70M	52.65M	78.35M	98.26M	103.56M
Profit After Tax (Quarter)	-78.48M	195.10M	203.61M	201.75M	179.01M	195.06M	210.48M	224.91M	232.50M	229.66M	219.42M	208.80M	300.49M	292.24M	311.36M	344.62M	365.04M	379.70M	348.54M	392.59M
Equity Income (Quarter)	-4.97M	-1.31M	5.61M	-4.40M	-1.74M	-6.28M	-3.28M	-2.83M	6.42M	-2.23M	-3.90M	0.74M	0.44M	0.87M	-0.68M	1.08M	-5.65M	11.41M	1.49M	1.51M
Income from Continuing Operations (Quarter)	-78.48M	195.10M	203.61M	201.75M	179.01M	195.06M	210.48M	224.91M	232.50M	229.66M	219.42M	208.80M	300.49M	292.24M	311.36M	344.62M	365.04M	379.70M	348.54M	392.59M
Consolidated Net Income (Quarter)	-78.48M	195.10M	203.61M	201.75M	179.01M	195.06M	210.48M	224.91M	232.50M	229.66M	219.42M	208.80M	300.49M	292.24M	311.36M	344.62M	365.04M	379.70M	348.54M	392.59M
Income towards Parent Company (Quarter)	-78.48M	195.10M	203.61M	201.75M	179.01M	195.06M	210.48M	224.91M	232.50M	229.66M	219.42M	208.80M	300.49M	292.24M	311.36M	344.62M	365.04M	379.70M	348.54M	392.59M
Net Income towards Common Stockholders (Quarter)	-78.48M	195.10M	203.61M	201.75M	179.01M	195.06M	210.48M	224.91M	232.50M	229.66M	219.42M	208.80M	300.49M	292.24M	311.36M	344.62M	365.04M	379.70M	348.54M	392.59M
Additional items
EPS (Basic) (Quarter)	-0.54	1.35	1.40	1.38	1.22	1.34	1.44	1.53	1.58	1.57	1.49	1.42	2.04	1.98	2.12	2.35	2.49	2.59	2.38	2.69
EPS (Weighted Average and Diluted) (Quarter)	-0.54	1.33	1.39	1.37	1.22	1.33	1.43	1.53	1.58	1.56	1.49	1.42	2.04	1.98	2.11	2.34	2.48	2.58	2.37	2.68
Shares Outstanding (Weighted Average) (Quarter)	145.22M	145.31M	145.68M	145.84M	145.97M	146.07M	146.43M	146.70M	146.68M	146.76M	147.07M	147.13M	146.96M	147.02M	146.86M	146.84M	146.72M	146.72M	146.18M	145.84M
Shares Outstanding (Diluted Average) (Quarter)	146.39M	146.45M	146.86M	147.04M	147.03M	147.04M	147.13M	147.37M	147.40M	147.46M	147.49M	147.54M	147.55M	147.55M	147.60M	147.48M	147.22M	147.34M	146.90M	146.63M
EBITDA (Quarter)	223.43M	241.64M	261.91M	248.71M	234.26M	255.40M	275.74M	280.19M	300.67M	275.27M	289.00M	275.09M	374.58M	381.22M	387.31M	417.24M	426.27M	454.54M	446.54M	491.66M
Interest Expenses (Quarter)	5.82M	5.65M	5.36M	5.95M	5.46M
Tax Rate (Quarter)	136.00%	18.44%	21.32%	14.98%	20.90%	18.07%	19.60%	17.82%	19.66%	17.03%	19.39%	19.52%	19.96%	18.31%	18.81%	17.62%	12.61%	17.10%	21.99%	20.87%

Research Tools

Resmed Income Statement (2009-2025) | RMD

Create an account

Sign In

Reset Password